Lung Ultrasound for Shortness of Breath
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test lung ultrasounds for individuals experiencing shortness of breath. Researchers compare different ultrasound devices and techniques to evaluate their effectiveness in examining the lungs. Participants will undergo two ultrasounds, one with AI assistance and one without, to gather data on lung conditions. Individuals with known or unknown lung issues who experience shortness of breath may be suitable for this study. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance lung diagnostics.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that lung ultrasound is safe for assessing shortness of breath?
Research has shown that lung ultrasounds, like those used in this study, are safe and easy for patients to handle. The Venue GO ultrasound machine is easy to carry and use in various settings. Although some reports mention battery issues, these can be managed by following safety instructions. This does not affect the ultrasound's safety, which remains non-invasive and risk-free for patients.
Similarly, the Vscan Air ultrasound machine provides quick and reliable images. It runs on batteries, is portable, and has undergone thorough durability testing, including drop tests. Its design ensures safe use in different environments, with no reported safety concerns for patients. Overall, both ultrasound machines are considered safe for use in clinical settings.12345Why are researchers excited about this trial?
Researchers are excited about using lung ultrasound for diagnosing shortness of breath because it offers a non-invasive and radiation-free way to assess lung conditions quickly. Unlike traditional imaging methods like X-rays or CT scans, these ultrasounds can be performed at a patient's bedside, providing immediate results. The trial explores two innovative ultrasound systems: the Venue GO system with Caption Lung AI and the Vscan Air handheld ultrasound with Caption AI. The AI-enhanced systems assist medical professionals in capturing high-quality images more efficiently, potentially improving diagnostic accuracy and speed. This approach could revolutionize how quickly and effectively healthcare providers diagnose and manage respiratory issues.
What evidence suggests that lung ultrasound is effective for shortness of breath?
Research has shown that lung ultrasounds effectively identify the causes of breathing difficulties. In this trial, participants will be divided into different cohorts to evaluate various ultrasound systems. Cohort 2 will use the Venue GO ultrasound system, which studies have found helps doctors quickly determine if the issue is with the heart or lungs, potentially shortening hospital stays and lowering costs. Cohort 1 will use the Vscan Air handheld ultrasound, known for its clear images and ease of use, making it a valuable tool in emergencies. Both devices enable doctors to view the lungs and nearby areas, improving the speed and accuracy of diagnosis. This can lead to better outcomes and quicker treatment for patients with breathing problems.678910
Are You a Good Fit for This Trial?
This trial is for patients experiencing shortness of breath who may have lung-related health issues. Specific eligibility criteria are not provided, so it's best to contact the study organizers for detailed requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Ultrasound Examination
Participants undergo lung ultrasound examinations using different devices and methods to collect diagnostic-quality images
Follow-up
Participants are monitored for image quality and inter-rater variability
What Are the Treatments Tested in This Trial?
Interventions
- Lung Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
GE Healthcare
Lead Sponsor
Fotis Vlachos
GE Healthcare
Chief Marketing Officer since 2024
PhD in Molecular Biology and Biochemistry from the University of Massachusetts, MBA from the Wharton School of the University of Pennsylvania
Peter J. Arduini
GE Healthcare
Chief Executive Officer since 2022
MBA from Northwestern University, BSc in Marketing from Susquehanna University
Rush University Medical Center
Collaborator
Yale University
Collaborator
Northwestern University
Collaborator